Disclaimer

A clinical trial on Knee Osteoarthritis is brought to your attention today!🦵 In this study, the treatment duration with mesenchymal stem cells (MSCs) initially appeared insufficient for evident cartilage repair. However, after a five-year follow-up period, subjects that received MSCs therapy consistently exhibited better outcomes compared to those in the control group.

More is better when it comes to treating knee osteoarthritis with umbilical cord derived-MSCs, suggests the following clinical study. Unlike the fleeting relief provided by single MSC doses or HA treatments, repeated MSC dosing consistently enhanced patient outcomes, revealing a promising avenue for long-term improvement. 💪

The Power of Combo in treating Knee Osteoarthritis! 💫 The attached clinical study showcases the effectiveness and safety of MSCs treatments, both independently and in conjunction with PRP. While treatments using MSCs alone have led to improvement,  the combination with PRP demonstrates a significantly higher mean percentage of improvement in patient outcomes. 

The implantation of autologous bone marrow derived-mesenchymal stromal cells in the case of Rheumatoid Arthritis is studied in the following article. This safe and well-tolerated intervention did not show any significant difference in the knee MRI scores but there is a trend towards improvement in some MSC-treated patients. 📈